Successful management of COVID‐19 and associated coagulopathy in a patient with durable left ventricular assist device
Kevin Hodges, Mujtaba Mubashir, Joshua E. Insler, Jerry D. Estep, Eileen Hsich, Michael Z. Tong, Steven R. Insler, Edward G. Soltesz
Abstract
Patients with durable left ventricular assist devices pose special problems for management in the setting of COVID-19 infection. We describe the successful management of a 44-year-old man with severe COVID-19 infection and HeartMate 3 left ventricular assist device. His course was complicated by cytokine storm and COVID-19-associated coagulopathy. We describe our institutional protocol for managing COVID-19 infection in patients on mechanical circulatory support, focusing on the need for a thoughtful, multidisciplinary approach.
Topics & Concepts
MedicineCoagulopathyCoronavirus disease 2019 (COVID-19)Cytokine stormIntensive care medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Multidisciplinary approachVentricular assist deviceCardiologyInternal medicineHeart failurePathologyInfectious disease (medical specialty)OutbreakDiseaseSociologySocial scienceMechanical Circulatory Support DevicesCardiac Structural Anomalies and RepairCardiac Arrest and Resuscitation